Reduction in the Risk of Prostate Cancer: Future Directions After the Prostate Cancer Prevention Trial
To access this article, please choose from the options below
Medical writing support in the preparation of this manuscript was provided by Katherine Carpenter and was funded by GlaxoSmithKline.
PII: S0090-4295(09)00931-5
doi:10.1016/j.urology.2009.05.099
© 2010 Elsevier Inc. All rights reserved.
